868550-22-5 Usage
Uses
Used in Synthetic Organic Chemistry:
(1S,2S,3R,4R,5S,6R)-1-azido-2,3,4,5,6-pentakis-benzyloxycyclohexane is used as a precursor compound for the synthesis of amines due to the reactivity of its azido group. (1S,2S,3R,4R,5S,6R)-1-azido-2,3,4,5,6-pentakis-benzyloxycyclohexane's unique structure and multiple stereocenters provide opportunities for the creation of complex organic molecules with potential applications in pharmaceuticals, materials science, and other fields.
Used in Click Chemistry:
The presence of the azido group in (1S,2S,3R,4R,5S,6R)-1-azido-2,3,4,5,6-pentakis-benzyloxycyclohexane makes it a candidate for use in click chemistry, a set of reactions that are highly efficient, modular, and tolerant of a wide range of conditions. (1S,2S,3R,4R,5S,6R)-1-azido-2,3,4,5,6-pentakis-benzyloxycyclohexane can be employed in the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, a type of click reaction that forms triazole rings, which are useful in the creation of bioconjugates, materials, and other complex molecular structures.
Used in Pharmaceutical Development:
Given the compound's potential to be a precursor to other bioactive molecules, (1S,2S,3R,4R,5S,6R)-1-azido-2,3,4,5,6-pentakis-benzyloxycyclohexane may be utilized in the pharmaceutical industry for the development of new drugs. Its chiral nature and the ability to undergo various chemical transformations make it a valuable intermediate in the synthesis of enantiomerically pure compounds with potential therapeutic applications.
Used in Materials Science:
(1S,2S,3R,4R,5S,6R)-1-azido-2,3,4,5,6-pentakis-benzyloxycyclohexane's structural features and the possibility of its derivatization through the azido group make it a candidate for use in the development of new materials with specific properties. For instance, it could be used in the synthesis of polymers, dendrimers, or other complex structures with tailored characteristics for applications in nanotechnology, sensors, or other advanced material technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 868550-22-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,8,5,5 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 868550-22:
(8*8)+(7*6)+(6*8)+(5*5)+(4*5)+(3*0)+(2*2)+(1*2)=205
205 % 10 = 5
So 868550-22-5 is a valid CAS Registry Number.
868550-22-5Relevant academic research and scientific papers
Regio- and stereoselective synthesis of aminoinositols and 1,2-diaminoinositols from conduritol B epoxide
Serrano, Pedro,Llebaria, Amadeu,Delgado, Antonio
, p. 7829 - 7840 (2007/10/03)
A systematic approach to the regio- and stereoselective synthesis of aminoinositols and 1,2-diaminoinositols arising from tetra-O-benzylconduritol B epoxide (9) and its aziridine analogue 22, respectively, is described. In all cases, the synthetic methodologies rely on the regio- and stereocontrolled azidolysis of the starting precursors to give the corresponding trans regioadducts. Subsequent functional group manipulation under strict configurational control affords the isomeric cis adducts. Chemoselective functionalization of the diamine moiety in 1,2-diaminoinositol derivatives can be achieved by the proper design of the reaction sequence and choice of reagents. The described protocols allow efficient access to each of the eight possible configurations of the 1,2-diamino and 1,2-amino alcohol moieties from chemical modifications of the epoxide moiety on the common precursor 9.
New aminocyclitols as modulators of glucosylceramide metabolism
Egido-Gabas, Meritxell,Serrano, Pedro,Casas, Josefina,Llebaria, Amadeu,Delgado, Antonio
, p. 1195 - 1201 (2007/10/03)
A series of 13 aminocyclitol derivatives belonging to two different families is described. Their configuration is governed by the regio- and stereocontrolled epoxide opening of a suitably protected conduritol-B epoxide. Studies on several glycosyl processing enzymes indicate that some of them are good inhibitors of glucosylceramide hydrolase. A rationale to account for preliminary structure-activity relationships is provided. The Royal Society of Chemistry 2005.
